Corvus Pharmaceuticals, Inc. (CRVS) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$19.26M*; Operating income -$19.30M; Depreciation and amortization $34.00K*.
- 2026-03-31: Basis Reported; EBITDA -$14.85M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$12.19M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$10.54M*; Operating income -$10.57M; Depreciation and amortization $28.00K*.
Complete source-backed ebitda history.
- Available history
- 2015-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$19.26M* | -$19.30M | $34.00K* | (m) | (m) | $582.00K* | -$15.40M* | (m) | $15.96M | (m) | $0.00* |
|---|
| 2026-03-31 | Reported | -$14.85M | (m) | (m) | (m) | (m) | $91.00K | -$10.37M | (m) | $11.18M | (m) | $0.00 |
|---|
| 2025-12-31 | Reported | -$12.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$10.54M* | -$10.57M | $28.00K* | (m) | (m) | $0.00* | -$9.57M* | (m) | $8.45M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$10.23M* | -$10.26M | $29.00K* | (m) | (m) | $113.00K* | -$5.78M* | (m) | $7.87M | (m) | $0.00* |
|---|
| 2025-03-31 | Reported | -$9.9M | (m) | (m) | (m) | (m) | $36.00K | -$8.26M | (m) | $7.45M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$8.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$7.23M* | -$7.25M | $21.00K* | (m) | (m) | (m) | -$6.32M* | (m) | $5.22M | (m) | $0.00* |
|---|
| 2024-06-30 | Reported | -$5.91M* | -$5.93M | $21.00K* | (m) | (m) | (m) | -$5.48M* | (m) | $4.11M | (m) | $0.00* |
|---|
| 2024-03-31 | Reported | -$6.23M | (m) | (m) | (m) | (m) | (m) | -$5.16M | (m) | $4.08M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$5.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$5.53M* | -$5.56M | $30.00K* | (m) | (m) | $0.00* | -$5.43M* | (m) | $3.96M | (m) | $0.00* |
|---|
| 2023-06-30 | Reported | -$5.59M* | -$5.62M | $36.00K* | (m) | (m) | $0.00* | -$5.22M* | (m) | $3.97M | (m) | $0.00* |
|---|
| 2023-03-31 | Reported | -$6.52M | (m) | (m) | (m) | (m) | $34.00K | -$8.11M | (m) | $4.59M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$5.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$12.38M* | -$12.47M | $94.00K* | (m) | (m) | $265.00K* | -$6.93M* | (m) | $10.37M | (m) | $0.00* |
|---|
| 2022-06-30 | Reported | -$6.92M* | -$7.01M | $92.00K* | (m) | (m) | (m) | -$6.12M* | (m) | $4.92M | (m) | $0.00* |
|---|
| 2022-03-31 | Reported | -$7.33M | (m) | (m) | (m) | (m) | (m) | -$6.42M | (m) | $5.10M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$6.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$8.94M* | -$9.05M | $108.00K* | (m) | (m) | (m) | -$8.43M* | (m) | $6.99M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | -$11.17M* | -$11.29M | $122.00K* | (m) | (m) | (m) | -$12.65M* | (m) | $9.11M | (m) | $0.00 |
|---|
| 2021-03-31 | Reported | -$11.35M | (m) | (m) | (m) | (m) | (m) | -$8.79M | (m) | $8.23M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$9.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$9.70M* | -$9.85M | $147.00K* | (m) | (m) | (m) | -$7.73M* | (m) | $6.62M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | -$10.61M* | -$10.77M | $159.00K* | (m) | (m) | (m) | -$9.49M* | (m) | $7.86M | (m) | $0.00 |
|---|
| 2020-03-31 | Reported | -$13.09M | (m) | (m) | (m) | (m) | (m) | -$9.35M | (m) | $10.16M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$11.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$11.33M* | -$11.51M | $186.00K* | (m) | (m) | $4.00K* | -$10.61M* | (m) | $9.00M | (m) | $0.00 |
|---|
| 2019-06-30 | Reported | -$13.41M* | -$13.60M | $186.00K* | (m) | (m) | $0.00* | -$9.21M* | (m) | $10.64M | (m) | $0.00 |
|---|
| 2019-03-31 | Reported | -$12.12M | (m) | (m) | (m) | (m) | $16.00K | -$8.99M | (m) | $9.42M | (m) | $0.00 |
|---|
| 2018-12-31 | Reported | -$10.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | -$10.92M* | -$11.15M | $228.00K* | (m) | (m) | $160.00K* | -$10.80M* | (m) | $8.37M | (m) | $0.00 |
|---|
| 2018-06-30 | Reported | -$12.04M* | -$12.26M | $220.00K* | (m) | (m) | $54.00K* | -$10.89M* | (m) | $9.71M | (m) | $0.00 |
|---|
| 2018-03-31 | Reported | -$14.43M | (m) | (m) | (m) | (m) | $6.00K | -$11.04M | (m) | $12.10M | (m) | $0.00 |
|---|
| 2017-12-31 | Reported | -$11.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2017-09-30 | Reported | -$12.73M* | -$12.94M | $211.00K* | (m) | (m) | $42.00K* | -$10.77M* | (m) | $10.73M | (m) | $0.00 |
|---|
| 2017-06-30 | Reported | -$14.97M* | -$15.17M | $208.00K* | (m) | (m) | $121.00K* | -$11.71M* | (m) | $12.39M | (m) | $0.00 |
|---|
| 2017-03-31 | Reported | -$16.01M | (m) | (m) | (m) | (m) | $111.00K | -$12.75M | (m) | $13.50M | (m) | $0.00 |
|---|
| 2016-09-30 | Reported | (m) | -$10.48M | (m) | (m) | (m) | $99.00K* | -$6.68M* | (m) | $7.71M | (m) | (m) |
|---|
| 2016-06-30 | Reported | (m) | -$8.82M | (m) | (m) | (m) | $873.00K* | (m) | (m) | $7.12M | (m) | (m) |
|---|
| 2016-03-31 | Reported | (m) | -$6.43M | (m) | (m) | (m) | $614.00K | (m) | (m) | $5.40M | (m) | (m) |
|---|
| 2015-09-30 | Reported | (m) | -$3.12M | (m) | (m) | (m) | $6.00K* | (m) | (m) | $2.51M | (m) | (m) |
|---|
| 2015-06-30 | Reported | (m) | -$2.33M | (m) | (m) | (m) | $553.00K* | (m) | (m) | $2.00M | (m) | (m) |
|---|
| 2015-03-31 | Reported | (m) | -$2.21M | (m) | (m) | (m) | $324.00K | (m) | (m) | $1.92M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$42.87M | (m) | (m) | (m) | (m) | $174.00K | -$32.80M | (m) | $33.72M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$27.46M | (m) | (m) | (m) | (m) | (m) | -$25.42M | (m) | $19.39M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$23.26M | (m) | (m) | (m) | (m) | $34.00K | -$23.93M | (m) | $16.53M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$32.2M | (m) | (m) | (m) | (m) | $269.00K | -$27.02M | (m) | $24.47M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$38.17M | (m) | (m) | (m) | (m) | $5.00K | -$36.72M | (m) | $29.11M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$43.13M | (m) | (m) | (m) | (m) | $76.00K | -$34.78M | (m) | $31.83M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$48.11M | (m) | (m) | (m) | (m) | $25.00K | -$37.32M | (m) | $37.98M | (m) | $0.00 |
|---|
| 2018-12-31 | Reported | -$48.38M | (m) | (m) | (m) | (m) | $355.00K | -$40.99M | (m) | $38.59M | (m) | $0.00 |
|---|
| 2017-12-31 | Reported | -$55.68M | (m) | (m) | (m) | (m) | $266.00K | -$46.21M | (m) | $46.30M | (m) | $0.00 |
|---|
| 2016-12-31 | Reported | -$36.38M | (m) | (m) | (m) | (m) | $2.20M | -$27.86M | (m) | $29.36M | (m) | $0.00 |
|---|
| 2015-12-31 | Reported | -$13.62M | (m) | (m) | (m) | (m) | $1.75M | -$11.33M | (m) | $11.35M | (m) | $0.00 |
|---|